Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know
10:39am, Thursday, 20'th Apr 2023
Novo Nordisk (NVO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Buy These 4 Low-Beta Stocks to Sail Through Market Volatility
09:10am, Thursday, 20'th Apr 2023
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Transportadora de Gas (TGS), Lamb Weston (LW), Vipshop (VIPS) and Novo Nordisk (NVO) are well-poised to gain.
Got $5,000? 2 Unstoppable Stocks to Buy and Hold Forever
08:30am, Thursday, 20'th Apr 2023
Novo Nordisk boasts a strong expertise in diabetes and other critical areas of medicine. Medtronic offers a rich and growing portfolio of products as well as a solid dividend.
7 Top Growth Stocks to Buy for the Next Decade
07:00am, Tuesday, 18'th Apr 2023
A the market returns it's time to look for the best growth stocks to buy. successful investing strategy partially requires an ability to predict the future.
Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs
07:01am, Monday, 17'th Apr 2023
The topic of weight loss drugs has been making recent headlines. The positive phase 1 clinical trial for Viking Therapeutics Inc. (NASDAQ: VKTX) GLP-1 treatment VK2735 caused its shares to rally more
Are You Looking for a Top Momentum Pick? Why Novo Nordisk (NVO) is a Great Choice
01:42pm, Friday, 14'th Apr 2023
Does Novo Nordisk (NVO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Novo Nordisk Has Some Room To Run
09:11am, Friday, 14'th Apr 2023
Shares have risen 20% over a month. Guidance was just upgraded.
Novo (NVO) & Aspect Biosystems Unite to Develop Tissue Therapy
06:14pm, Thursday, 13'th Apr 2023
Pharma Goliath Novo Nordisk (NVO) inks collaboration agreement with Aspect Biosystems to develop and commercialize transformative cell therapy treatments for type I diabetes patients.
KALA Up on Fast Track Designation to Lead Ocular Candidate
12:56pm, Thursday, 13'th Apr 2023
KALA gets Fast Track Designation from the FDA for lead candidate KPI-012 to treat persistent corneal epithelial defects.
Novo Nordisk Surges To Another Record As Obesity Drugs Drive Higher Outlook
10:25am, Thursday, 13'th Apr 2023
Novo Nordisk stock forged a new high Thursday after raising financial estimates, citing its diabetes and obesity treatments. The post Novo Nordisk Surges To Another Record As Obesity Drugs Drive Highe
Novo Nordisk Charges Higher and Could be Just Getting Started
08:47am, Thursday, 13'th Apr 2023
Shares of Novo Nordisk A/S (NYSE: NVO) are up over 3.6% on April 12. The immediate catalyst is the announcement of a $2.6 billion collaboration with Aspect Biosystems.
Novo Nordisk: Maybe It's Time To Trim The Position A Little Bit
05:42am, Thursday, 13'th Apr 2023
Novo Nordisk is trading for one of the highest valuation multiples in the last 20 years, and we should be cautious. Nevertheless, the company reported great results for fiscal 2022 and is also expecti
Why Wegovy and Ozempic Could Be Cash Cows for Novo Nordisk
10:00am, Wednesday, 12'th Apr 2023
Wegovy and Ozempic sales have skyrocketed on their ability to help people shed pounds. Novo Nordisk is working hard to ramp up production to meet this strong demand.
Is Novo Nordisk (NVO) a Buy as Wall Street Analysts Look Optimistic?
10:41am, Monday, 10'th Apr 2023
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Is Novo Nordisk Stock a Buy Now?
09:55am, Monday, 10'th Apr 2023
Novo Nordisk is raking in big bucks thanks to sales of semaglutide. Its shares are quite pricey thanks to widespread optimism about its trajectory.
